Next Article in Journal
Sodium Valproate Incompatibility with Parenteral Nutrition Admixtures—A Risk to Patient Safety: An In Vitro Evaluation Study
Next Article in Special Issue
Liposomes as Tools to Improve Therapeutic Enzyme Performance
Previous Article in Journal
Applicability of RPMI 2650 and Calu-3 Cell Models for Evaluation of Nasal Formulations
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(2), 370; https://doi.org/10.3390/pharmaceutics14020370
Action Date Notes Link
article pdf uploaded. 7 February 2022 12:48 CET Version of Record https://www.mdpi.com/1999-4923/14/2/370/pdf-vor
article supplementary file uploaded. 7 February 2022 12:48 CET - https://www.mdpi.com/1999-4923/14/2/370#supplementary
article pdf uploaded. 7 February 2022 12:55 CET Updated version of record https://www.mdpi.com/1999-4923/14/2/370/pdf-vor
article supplementary file uploaded. 9 February 2022 04:28 CET - https://www.mdpi.com/1999-4923/14/2/370#supplementary
article xml file uploaded 11 February 2022 11:21 CET Original file -
article xml uploaded. 11 February 2022 11:21 CET Update https://www.mdpi.com/1999-4923/14/2/370/xml
article pdf uploaded. 11 February 2022 11:21 CET Updated version of record https://www.mdpi.com/1999-4923/14/2/370/pdf
article html file updated 11 February 2022 11:22 CET Original file -
article html file updated 31 July 2022 11:39 CEST Update https://www.mdpi.com/1999-4923/14/2/370/html
Back to TopTop